Randomization was stratified by chemotherapy choice (capecitabine, eribulin, gemcitabine, or vinorelbine), number of lines of therapy in the metastatic setting (≤ 2, > 2), and number of metastatic sites (≤ 2, > 2). The trial was conducted at 166 sites in the United States and 16 other countries.It was approved for medical use in the United States in December 2020. References
External links
"Margetuximab". Drug Information Portal. U.S. National Library of Medicine.
Cases of combined simultaneous abdominal and intrauterine pregnancy have been reported. References


== External links ==